Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1591 AL 1605

Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease

Kabir MT, Uddin MS, Zaman S, Begum Y, Ashraf GM, Bin-Jumah MN, Bungau SG, Mousa SA, Abdel-Daim MM.

Mol Neurobiol. 2021 Jan;58(1):1-20. doi: 10.1007/s12035-020-02096-w. Epub 2020 Sep 5.

The Sleep Side of Aging and Alzheimer's Disease

Romanella SM, Roe D, Tatti E, Cappon D, Paciorek R, Testani E, Rossi A, Rossi S, Santarnecchi E.

Sleep Med. 2021 Jan;77:209-225. doi: 10.1016/j.sleep.2020.05.029. Epub 2020 May 30.

Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets

Uddin MS, Al Mamun A, Kabir MT, Ashraf GM, Bin-Jumah MN, Abdel-Daim MM.

Mol Neurobiol. 2021 Jan;58(1):281-303. doi: 10.1007/s12035-020-02116-9. Epub 2020 Sep 15.

A Systematic Review of Altered P300 Event-Related Potential in Apolipoprotein E4 (APOE4) Carriers

Pedroso RV, Fraga FJ, Pavarini SCI, Nascimento CMC, Ayán C, Cominetti MR.

Clin EEG Neurosci. 2021 May;52(3):193-200. doi: 10.1177/1550059420959966. Epub 2020 Sep 18.

Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease

Goyal D, Ali SA, Singh RK.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110112. doi: 10.1016/j.pnpbp.2020.110112. Epub 2020 Sep 16.

d-serine in physiological and pathological brain aging

Ploux E, Freret T, Billard JM.

Biochim Biophys Acta Proteins Proteom. 2021 Jan;1869(1):140542. doi: 10.1016/j.bbapap.2020.140542. Epub 2020 Sep 18.

Tubulin modifying enzymes as target for the treatment of tau-related diseases

Rogowski K, Hached K, Crozet C, van der Laan S.

Pharmacol Ther. 2021 Feb;218:107681. doi: 10.1016/j.pharmthera.2020.107681. Epub 2020 Sep 19.

Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease

Bonfili L, Cecarini V, Gogoi O, Gong C, Cuccioloni M, Angeletti M, Rossi G, Eleuteri AM.

FEBS J. 2021 May;288(9):2836-2855. doi: 10.1111/febs.15571. Epub 2020 Oct 8.

Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder

Kshirsagar V, Thingore C, Juvekar A.

Metab Brain Dis. 2021 Jan;36(1):67-83. doi: 10.1007/s11011-020-00622-2. Epub 2020 Sep 28.

One call makes a difference: An evaluation of the Alzheimer's Association National Helpline on dementia caregiver outcomes

Hodgson NA, Petrovsky DV, Finegan K, Kallmyer BA, Pike J, Fazio S.

Patient Educ Couns. 2021 Apr;104(4):896-902. doi: 10.1016/j.pec.2020.09.026. Epub 2020 Sep 23.

Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)

Rombouts F, Kusakabe KI, Hsiao CC, Gijsen HJM.

Expert Opin Ther Pat. 2021 Jan;31(1):25-52. doi: 10.1080/13543776.2021.1832463. Epub 2020 Dec 17.

From bedside to battlefield: intersection of ketone body mechanisms in geroscience with military resilience

Stubbs BJ, Koutnik AP, Volek JS, Newman JC.

Geroscience. 2021 Jun;43(3):1071-1081. doi: 10.1007/s11357-020-00277-y. Epub 2020 Oct 2.

Leading the way in the nervous system: Lipid Droplets as new players in health and disease

Teixeira V, Maciel P, Costa V.

Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Jan;1866(1):158820. doi: 10.1016/j.bbalip.2020.158820. Epub 2020 Oct 1.

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F.

Neuropharmacology. 2021 Jun 1;190:108352. doi: 10.1016/j.neuropharm.2020.108352. Epub 2020 Oct 6.

Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease

Ma WH, Chen AF, Xie XY, Huang YS.

Neuropharmacology. 2021 Jun 1;190:108342. doi: 10.1016/j.neuropharm.2020.108342. Epub 2020 Oct 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias